Skip to main content
KOWA CO.,LTD. logo

KOWA CO.,LTD. — Investor Relations & Filings

Ticker · 7807 ISIN · JP3292900002 LEI · 353800AVPSFI46030813 T Manufacturing
Open in API
Filings indexed 73 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country JP Japan
Listing T 7807

About KOWA CO.,LTD.

https://www.kowa.co.jp/eng/

Kowa Co., Ltd. is a diversified company that integrates manufacturing and trading operations across several business units. The company's trading arm manages the import, export, and sale of a wide range of products, including textiles, machinery, and construction materials. In the life science and healthcare sector, Kowa develops, manufactures, and markets pharmaceuticals, over-the-counter health products, and medical devices, with a notable specialization in ophthalmic diagnostic equipment. The company is also a prominent manufacturer of high-performance optical products, such as binoculars and spotting scopes, under its Prominar brand. Additionally, Kowa operates a hospitality business, managing hotels and other related services.

Recent filings

Filing Released Lang Actions
支配株主等に関する事項について
Regulatory Filings Classification · 80% confidence The document is a notification disclosing the company’s controlling shareholder and related governance measures as of a specific date. It does not present financial statements, earnings, or AGM materials, nor does it reflect a threshold crossing notification but rather a compliance disclosure of controlling-shareholder information. This fits a general regulatory announcement category.
2026-05-29 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a Japanese 臨時報告書 (timely/extraordinary report) filed under the Financial Instruments and Exchange Act. It discloses the resolutions passed at the company’s 39th Annual General Meeting held on May 28, 2026, specifically the election of four directors, and provides detailed vote counts for each nominee. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting.
2026-05-28 Japanese
確認書
Regulatory Filings Classification · 90% confidence The document is a “確認書” (confirmation letter) under Japan’s Financial Instruments and Exchange Act, in which the CEO certifies that the annual securities report (有価証券報告書) for the fiscal year is properly stated. It does not contain the actual financial statements or full report itself, but is an officer’s attestation. Under the Certification Rule, such a document is classified as a general regulatory filing (RNS), not as the actual annual report.
2026-05-28 Japanese
有価証券報告書－第39期(2025/03/01－2026/02/28)
Annual Report Classification · 95% confidence The document is a full-length “有価証券報告書” (Yuuka Shoken Hokokusho) filed under the Financial Instruments and Exchange Act, covering the company’s full fiscal year (FY ending Feb 28, 2026) with detailed consolidated financial statements and business segment disclosures. This is the Japanese equivalent of an annual report (10-K), not merely an announcement or supplement. FY 2026
2026-05-28 Japanese
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
Regulatory Filings Classification · 85% confidence The document is a press release announcing non-clinical data and an upcoming scientific presentation at the AACR Annual Meeting. It contains no financial results, governance changes, share transactions, or other structured regulatory filings. It is not an investor presentation or management report; rather it is a general corporate news announcement. Therefore, it falls into the fallback category for miscellaneous regulatory announcements (RNS).
2026-04-06 English
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan. It accompanies the Second Quarter Report (第２四半期報告書) to confirm the accuracy of the financial statements. Since this is a regulatory filing required by law to accompany financial reports and does not fit into specific categories like earnings releases or annual reports, it is classified as a Regulatory Filing (RNS).
2025-10-15 Japanese

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.